The interplay between host immune cells and gut microbiota in chronic inflammatory diseases.
Donghyun KimMelody Y ZengGabriel NúñezPublished in: Experimental & molecular medicine (2017)
Many benefits provided by the gut microbiota to the host rely on its intricate interactions with host cells. Perturbations of the gut microbiota, termed gut dysbiosis, affect the interplay between the gut microbiota and host cells, resulting in dysregulation of inflammation that contributes to the pathogenesis of chronic inflammatory diseases, including inflammatory bowel disease, multiple sclerosis, allergic asthma and rheumatoid arthritis. In this review, we provide an overview of how gut bacteria modulates host metabolic and immune functions, summarize studies that examined the roles of gut dysbiosis in chronic inflammatory diseases, and finally discuss measures to correct gut dysbiosis as potential therapeutics for chronic inflammatory diseases.
Keyphrases
- oxidative stress
- induced apoptosis
- multiple sclerosis
- rheumatoid arthritis
- cell cycle arrest
- chronic obstructive pulmonary disease
- drug induced
- cell proliferation
- signaling pathway
- endoplasmic reticulum stress
- lung function
- climate change
- systemic lupus erythematosus
- risk assessment
- systemic sclerosis
- interstitial lung disease
- air pollution
- pi k akt
- human health